Gamithromycin

Gamithromycin | Veterinary Antibiotic for BRD Treatment, High Purity 99%‌

✧ ‌Product Overview‌

Gamithromycin is a ‌second-generation macrolide veterinary antibiotic‌ approved by the EU in 2007 for ‌bovine respiratory disease (BRD)‌ treatment‌
. It targets pathogens like Mannheimia haemolytica and Pasteurella multocida through bacterial protein synthesis inhibition‌
. Ideal for ‌non-lactating cattle‌, it offers ‌single-dose efficacy‌, rapid absorption, and low residue compliance‌.

✧ ‌Key Advantages‌

🔹 ‌Single-Dose Convenience‌

• Prolonged therapeutic effect with ‌>99% purity‌ (USP/EP standards)‌.

• Reduces livestock handling stress‌.

🔹 ‌Safety & Broad-Spectrum Activity‌

• Meets strict withdrawal periods for food safety‌1.

• Effective against ‌Gram-positive/negative bacteria‌ and mycoplasma‌.

✧ ‌Applications‌

• ‌Cattle BRD‌: Primary use for respiratory infections‌.

• ‌Poultry/Swine‌: Emerging applications‌.

• ‌Preventive Care‌: Reduces herd morbidity‌.

✧ ‌Quality & Market‌

• Complies with ‌USP/EP/BP‌ standards‌.

• Supported by a ‌growing veterinary antibiotics market‌ driven by livestock productivity demands‌.

•